Microviable Therapeutics

Gijón, Spain

Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.

$1.6M raised

Apr 2022

Seed

Health Care Life Science

Top Investors

Immunomet Intolerance and Dysbiosis

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Microviable Therapeutics

How much funding has Microviable Therapeutics raised?

Microviable Therapeutics has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in April 2022.

Who are Microviable Therapeutics's investors?

Microviable Therapeutics's investors include Immunomet Intolerance and Dysbiosis.

Where is Microviable Therapeutics headquartered?

Microviable Therapeutics is headquartered in Gijón, Spain.

What does Microviable Therapeutics do?

Microviable Therapeutics develops microbiota ecosystem products and microbiome therapies to improve human health.

What stage is Microviable Therapeutics at?

Microviable Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 19, 2022.

MLA

"Microviable Therapeutics — Funding & Investors." VCBacked, April 19, 2022, https://www.vcbacked.co/company/microviable-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2022). Microviable Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/microviable-therapeutics

Wikipedia (cite web)

{{cite web |title=Microviable Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/microviable-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 19, 2022.